Chevy Chase Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$152M Buy
310,001
+9,528
+3% +$5.17M 0.44% 43
2025
Q4
$174M Buy
300,473
+10,704
+4% +$6.05M 0.47% 31
2025
Q3
$141M Buy
289,769
+17,687
+7% +$8.23M 0.39% 39
2025
Q2
$110M Buy
272,082
+29,510
+12% +$12.3M 0.32% 58
2025
Q1
$121M Buy
242,572
+22,368
+10% +$12.1M 0.39% 52
2024
Q4
$115M Sell
220,204
-22,068
-9% -$12.1M 0.35% 48
2024
Q3
$150M Buy
242,272
+32,397
+15% +$19.2M 0.46% 39
2024
Q2
$116M Sell
209,875
-5,970
-3% -$3.42M 0.37% 51
2024
Q1
$125M Sell
215,845
-1,755
-0.8% -$985K 0.41% 48
2023
Q4
$115M Sell
217,600
-857
-0.4% -$415K 0.41% 51
2023
Q3
$111M Sell
218,457
-4,922
-2% -$2.62M 0.44% 47
2023
Q2
$117M Sell
223,379
-6,439
-3% -$3.47M 0.44% 47
2023
Q1
$132M Buy
229,818
+1,557
+0.7% +$878K 0.52% 38
2022
Q4
$126M Sell
228,261
-12,984
-5% -$6.88M 0.53% 41
2022
Q3
$122M Buy
241,245
+2,129
+0.9% +$1.19M 0.52% 39
2022
Q2
$130M Sell
239,116
-258
-0.1% -$142K 0.54% 36
2022
Q1
$141M Buy
239,374
+381
+0.2% +$219K 0.49% 38
2021
Q4
$159M Sell
238,993
-5,284
-2% -$3.3M 0.51% 36
2021
Q3
$140M Sell
244,277
-9,058
-4% -$4.97M 0.49% 41
2021
Q2
$128M Sell
253,335
-15,213
-6% -$7.18M 0.43% 48
2021
Q1
$123M Sell
268,548
-20,656
-7% -$9.86M 0.44% 48
2020
Q4
$135M Sell
289,204
-7,370
-2% -$3.46M 0.48% 43
2020
Q3
$131M Sell
296,574
-24,591
-8% -$10.2M 0.52% 39
2020
Q2
$116M Sell
321,165
-22,860
-7% -$7.66M 0.47% 44
2020
Q1
$97.6M Buy
344,025
+5,315
+2% +$1.68M 0.45% 52
2019
Q4
$110M Buy
338,710
+1,132
+0.3% +$343K 0.42% 57
2019
Q3
$98.3M Buy
337,578
+548
+0.2% +$157K 0.4% 63
2019
Q2
$99M Sell
337,030
-1,823
-0.5% -$502K 0.41% 59
2019
Q1
$94M Buy
338,853
+4,471
+1% +$1.11M 0.39% 63
2018
Q4
$74.8M Buy
334,382
+600
+0.2% +$141K 0.37% 68
2018
Q3
$81.5M Sell
333,782
-7,893
-2% -$1.82M 0.34% 75
2018
Q2
$70.8M Sell
341,675
-583
-0.2% -$124K 0.31% 77
2018
Q1
$70.7M Sell
342,258
-7,888
-2% -$1.66M 0.31% 76
2017
Q4
$66.5M Sell
350,146
-721
-0.2% -$138K 0.29% 86
2017
Q3
$66.4M Buy
350,867
+11,453
+3% +$2.07M 0.3% 80
2017
Q2
$59.2M Buy
339,414
+1,300
+0.4% +$218K 0.28% 87
2017
Q1
$51.9M Buy
338,114
+5,944
+2% +$909K 0.25% 97
2016
Q4
$46.9M Buy
332,170
+1,284
+0.4% +$189K 0.25% 97
2016
Q3
$52.6M Sell
330,886
-6,966
-2% -$1.07M 0.29% 84
2016
Q2
$49.9M Buy
337,852
+1,802
+0.5% +$266K 0.28% 85
2016
Q1
$47.6M Buy
336,050
+5,301
+2% +$710K 0.27% 88
2015
Q4
$46.9M Sell
330,749
-20,828
-6% -$2.78M 0.28% 88
2015
Q3
$43M Buy
351,577
+11,103
+3% +$1.45M 0.27% 86
2015
Q2
$44.2M Sell
340,474
-2,241
-0.7% -$292K 0.26% 93
2015
Q1
$46M Buy
342,715
+5,385
+2% +$694K 0.28% 89
2014
Q4
$42.3M Sell
337,330
-4,509
-1% -$548K 0.26% 101
2014
Q3
$41.6M Buy
341,839
+28,182
+9% +$3.43M 0.27% 92
2014
Q2
$37M Sell
313,657
-4,566
-1% -$537K 0.26% 94
2014
Q1
$38.3M Buy
318,223
+4,181
+1% +$497K 0.27% 88
2013
Q4
$35M Buy
314,042
+4,341
+1% +$432K 0.26% 94
2013
Q3
$28.5M Buy
309,701
+6,662
+2% +$602K 0.23% 106
2013
Q2
$25.6M Buy
+303,039
New +$25.2M 0.22% 108

Other funds holding TMO

Chevy Chase Trust's TMO Position: Q1 2026 in Review

Chevy Chase Trust increased its Thermo Fisher Scientific (TMO) stake by 3.2% in Q1 2026, buying an estimated $5.17M and bringing the position to 310,001 shares worth $152M. The position accounts for 0.44% of the portfolio, ranked #43.

Chevy Chase Trust first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $174M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Chevy Chase Trust held 310,001 shares of Thermo Fisher Scientific worth $152M as of Q1 2026.
  • Chevy Chase Trust bought 9,528 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.17M.
  • Thermo Fisher Scientific made up 0.44% of Chevy Chase Trust's portfolio in Q1 2026, its #43 holding.
  • Chevy Chase Trust first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Chevy Chase Trust's Thermo Fisher Scientific position peaked at $174M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.